Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial

BackgroundThe CIAO trial recently demonstrated a probable clinical benefit of omalizumab in the treatment of severe COVID-19; however, the mechanism underlying this benefit remains unclear. Therefore, we sought to longitudinally assess the impact of omalizumab on serum cytokines in CIAO trial patien...

Full description

Saved in:

Bibliographic Details
Main Authors:	Connor Prosty, Michelle Le, Yang Lu, Lauren Khoury, Maxime Cormier, Mathew P. Cheng, Robert Fowler, Srinivas Murthy, Jennifer LY Tsang, Duncan Lejtenyi, Moshe Ben-Shoshan, Elham Rahme, Shirin Golchi, Nandini Dendukuri, Todd C. Lee, Elena Netchiporouk
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Medicine
Subjects:	omalizumab coronavirus COVID-19 clinical trial cytokine
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1437322/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial

Similar Items